Medicine
| ISSN | 23529067 |
|---|---|
| Country | Netherlands |
| Publisher | Elsevier BV |
| Subject Areas | Medicine |
| Publication Type | Journals |
| Active Years | 2014-2021 |
| Website | Visit journal |
| JIF 2022–2023 | 2.500 |
IJC HeartVasculature is an onlineonly openaccess journal dedicated to publishing original articles and reviews also Editorials and Letters to the Editor which report on structural and functional cardiovascular pathology with an emphasis on imaging and disease pathophysiology.Articles must be authentic educational clinically relevant and original in their content and scientific approach.IJC HeartVasculature requires the highest standards of scientific integrity in order to promote reliable reproducible and verifiable research findings. All authors are advised to consult the Principles of Ethical Publishing in the International Journal of Cardiology before submitting a manuscript. Submission of a manuscript to this journal gives the publisher the right to publish that paper if it is accepted. Manuscripts may be edited to improve clarity and expression.
| Year | 2-Year IF | 3-Year IF | 4-Year IF |
|---|---|---|---|
| 2023 | 2.281 | 2.229 | 2.128 |
| 2022 | 2.473 | 2.472 | 2.404 |
| 2021 | 2.304 | 2.274 | 2.277 |
| 2020 | 2.254 | 2.284 | 2.372 |
| 2019 | 2.378 | 2.331 | 1.891 |
| 2018 | 1.831 | 1.416 | 1.322 |
| 2017 | 0.892 | 0.826 | 0.826 |
| 2016 | 0.705 | 0.705 | 0.705 |
| 2015 | 0.786 | 0.786 | 0.786 |
Note: impact factor data for reference only.
SJR measures scientific influence, weighting citations by the prestige of the citing journal.
| Year | SJR Score |
|---|---|
| 2023 | 0.753 |
| 2022 | 0.839 |
| 2021 | 0.803 |
| 2020 | 0.813 |
| 2019 | 0.810 |
| 2018 | 0.488 |
| 2017 | 0.342 |
| 2016 | 0.276 |
| 2015 | 0.194 |
The H-Index measures both the productivity and citation impact of a journal's publications.
| Year | H-Index |
|---|---|
| 2023 | 33.000 |
| 2022 | 30.000 |
| 2021 | 25.000 |
https://www.evise.com/profile/#/IJCHA/login